Literature DB >> 36114889

Echocardiogram screening in pediatric dialysis and transplantation.

Amelia K Le Page1,2, Naganandini Nagasundaram3, Ari E Horton4,5,6, Lilian M Johnstone3,4.   

Abstract

Transthoracic echocardiography is commonly used to identify structural and functional cardiac abnormalities that can be prevalent in childhood chronic kidney failure (KF). Left ventricular mass (LVM) increase is most frequently reported and may persist post-kidney transplant especially with hypertension and obesity. While systolic dysfunction is infrequently seen in childhood chronic KF, systolic strain identified by speckle tracking echocardiography has been frequently identified in dialysis and it can also persist post-transplant. Echocardiogram association with long-term outcomes has not been studied in childhood KF but there are many adult studies demonstrating associations between increased LVM, systolic dysfunction, strain, diastolic dysfunction, and cardiovascular events and mortality. There has been limited study of interventions to improve echocardiogram status. In childhood, improved blood pressure has been associated with better LVM, and conversion from hemodialysis to hemodiafiltration has been associated with better diastolic and systolic function. Whether long-term cardiac outcomes are also improved with these interventions is unclear. Echocardiography is a well-established technique, and regular use in childhood chronic KF seems justified. A case can be made to extend screening to include speckle tracking echocardiography and intradialytic studies in high-risk populations. Further longitudinal studies including these newer echocardiogram modalities, interventions, and long-term outcomes would help clarify recommendations for optimal use as a screening tool.
© 2022. The Author(s).

Entities:  

Keywords:  Cardiovascular; Children; Chronic kidney failure; Dialysis; Echocardiography; Transplant

Year:  2022        PMID: 36114889     DOI: 10.1007/s00467-022-05721-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.651


  92 in total

Review 1.  Alterations of arterial function in end-stage renal disease.

Authors:  G M London
Journal:  Nephron       Date:  2000-02       Impact factor: 2.847

2.  Sudden cardiac death in dialysis patients: different causes and management strategies.

Authors:  Simonetta Genovesi; Giuseppe Boriani; Adrian Covic; Robin W M Vernooij; Christian Combe; Alexandru Burlacu; Andrew Davenport; Mehmet Kanbay; Dimitrios Kirmizis; Daniel Schneditz; Frank van der Sande; Carlo Basile
Journal:  Nephrol Dial Transplant       Date:  2021-02-20       Impact factor: 5.992

3.  Hypertension in pediatric patients on long-term dialysis: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS).

Authors:  Mark Mitsnefes; Donald Stablein
Journal:  Am J Kidney Dis       Date:  2005-02       Impact factor: 8.860

4.  Left ventricular mass and systolic performance in pediatric patients with chronic renal failure.

Authors:  Mark M Mitsnefes; Thomas R Kimball; Sandra A Witt; Betty J Glascock; Philip R Khoury; Stephen R Daniels
Journal:  Circulation       Date:  2003-02-18       Impact factor: 29.690

5.  Systemic arterial hypertension in children following renal transplantation: prevalence and risk factors.

Authors:  Manish D Sinha; Larissa Kerecuk; Julie Gilg; Christopher J D Reid
Journal:  Nephrol Dial Transplant       Date:  2012-02-10       Impact factor: 5.992

Review 6.  Cardiovascular Disease Risk Factors in Chronic Kidney Disease in Children.

Authors:  Mark M Mitsnefes
Journal:  Semin Nephrol       Date:  2021-09       Impact factor: 4.472

Review 7.  Left ventricular hypertrophy in renal failure.

Authors:  K Amann; I Rychlík; G Miltenberger-Milteny; E Ritz
Journal:  Kidney Int Suppl       Date:  1998-12       Impact factor: 10.545

Review 8.  Risk factors for cardiovascular disease in pediatric renal transplant recipients.

Authors:  Douglas M Silverstein
Journal:  Pediatr Transplant       Date:  2004-08

9.  Kidney transplantation halts cardiovascular disease progression in patients with end-stage renal disease.

Authors:  Herwig-Ulf Meier-Kriesche; Jesse D Schold; Titte R Srinivas; Alan Reed; Bruce Kaplan
Journal:  Am J Transplant       Date:  2004-10       Impact factor: 8.086

10.  Long-term survival of children with end-stage renal disease.

Authors:  Stephen P McDonald; Jonathan C Craig
Journal:  N Engl J Med       Date:  2004-06-24       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.